Invention Grant
- Patent Title: Combination therapy involving diaryl macrocyclic compounds
-
Application No.: US17104739Application Date: 2020-11-25
-
Publication No.: US11666574B2Publication Date: 2023-06-06
- Inventor: Wei Deng , Dayong Zhai , Laura Rodon , Brion W. Murray , Jingrong J. Cui , Nathan V. Lee
- Applicant: TURNING POINT THERAPEUTICS, INC.
- Applicant Address: US CA San Diego
- Assignee: Turning Point Therapeutics, Inc.
- Current Assignee: Turning Point Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Main IPC: A61K31/519
- IPC: A61K31/519
Abstract:
The present disclosure relates to methods and compositions for treating cancer with a diaryl macrocycle in combination with an inhibitor of MAPK/ERK kinase-1 and -2 (MEK1 and MEK2; MAP2K1 and MAP2K2), such as trametinib.
Public/Granted literature
- US20210154198A1 COMBINATION THERAPY INVOLVING DIARYL MACROCYCLIC COMPOUNDS Public/Granted day:2021-05-27
Information query
IPC分类:
